Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Neurology|October 22, 1998
Cost-effectiveness model of adjunctive lamotrigine for the treatment of epilepsyM A Markowitz, J A Mauskopf, M T Halpern
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 10, 2002
Conditions for the near equivalence of cost-effectiveness and cost-benefit analysesMohan V Bala, Gary A Zarkin, Josephine A Mauskopf
Journal of Health Politics, Policy and Law|December 12, 1997
Medicaid managed care and the family planning free-choice exemption: beyond the freedom to chooseS Rosenbaum, P W Shin, A Mauskopf, et al.
Journal of Occupational Medicine. : Official Publication of the Industrial Medical Association|June 1, 1991
Benefit-cost analysis of hepatitis B vaccine programs for occupationally exposed workersJ A Mauskopf, C J Bradley, M T French
Pharmacoeconomics|May 27, 1999
Willingness to pay as a measure of health benefitsM V Bala, J A Mauskopf, L L Wood
European Journal of Obstetrics, Gynecology, and Reproductive Biology|May 6, 2009
Rate, type, and cost of pelvic organ prolapse surgery in Germany, France, and EnglandDhinagar Subramanian, Karine Szwarcensztein, Josephine A Mauskopf, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|January 18, 2017
A cost-effectiveness analysis of lisdexamfetamine dimesylate in the treatment of adults with attention-deficit/hyperactivity disorder in the UKEvelina A Zimovetz, Alain Joseph, Rajeev Ayyagari, et al.
American Journal of Public Health|May 1, 1993
Potential health benefits of nutrition label changesG A Zarkin, N Dean, J A Mauskopf, et al.
Pageof 5